Inhibition of AhR improves cortical bone and skeletal muscle function via preservation of neuromuscular junctions
JCI Insight · 2025
DOI: 10.1172/jci.insight.192047 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Kanglun Yu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Biology and Anatomy, Medical College of Georgia. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Muscle, Skeletal, Neuromuscular Junction, Cortical Bone. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIAMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
The aryl hydrocarbon receptor (AhR) is proposed to mediate the frailty-promoting effects of the tryptophan metabolite kynurenine, which increases with age in mice and humans. The goal of the current study was to test whether administration of pharmacological AhR inhibitors, BAY2416964 and CH-223191, could abrogate musculoskeletal decline in aging mice. Female C57BL/6 mice (18 months old) were treated with vehicle (VEH) or 30 mg/kg BAY2416964 (BAY) via daily oral gavage 5 days/week for 8 weeks. A second AhR antagonist, CH-223191, was administered to 16-month-old male and female C57BL/6 mice via intraperitoneal injections (3.3 mg/kg) 3 days/week for 12 weeks. While grip strength declined over time in VEH-treated mice, BAY preserved grip strength in part by improving integrity of neuromuscular junctions (NMJs), an effect replicated during in vitro studies with siRNA against AhR. Cortical bone mass was also greater in BAY- than VEH-treated mice. Similarly, CH-223191 treatment improved cortical bone and showed beneficial effects in skeletal muscle, including reducing oxidative stress as compared with VEH-treated animals. Transcriptomic and proteomic data from BAY-treated mice supported a positive impact of BAY on molecular targets that affect NMJ function. Taken together, these data support AhR as a therapeutic target for improving musculoskeletal health during aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular Biology and Anatomy, Medical College of Georgia.
- Department of Medicine, Medical College of Georgia.
- Department of Neuroscience & Regenerative Medicine, Medical College of Georgia.
- Georgia Cancer Center.
- Department of Oral Biology & Diagnostic Sciences, Dental College of Georgia.
- Department Biostatistics, Data Science & Epidemiology, School of Public Health, and.
Förderung
- NIA NIH HHS
- NIAMS NIH HHS
- NIH HHS
- National Institute on Aging
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NIH Office of the Director
- Veterans Administration Medical Center
Zitieren
APA
Yu, K., Vyavahare, S., Alhamad, D., Bensreti, H., Ruan, L., Tuladhar, A., Dai, C., Shaver, J. C., Tripathi, A., Ding, K., Pacholczyk, R., Cooley, M. A., Zhong, R., Johnson, M. H., Chen, J., Bollag, W. B., Isales, C. M., Hill, W. D., Hamrick, M. W., …, & McGee-Lawrence, M. E. (2025). Inhibition of AhR improves cortical bone and skeletal muscle function via preservation of neuromuscular junctions. JCI Insight. https://doi.org/10.1172/jci.insight.192047
Vancouver
Yu K, Vyavahare S, Alhamad D, Bensreti H, Ruan L, Tuladhar A, et al. Inhibition of AhR improves cortical bone and skeletal muscle function via preservation of neuromuscular junctions. JCI Insight. 2025. doi:10.1172/jci.insight.192047
BibTeX
@article{Yu2025,
author = {Yu, Kanglun and Vyavahare, Sagar and Alhamad, Dima and Bensreti, Husam and Ruan, Ling and Tuladhar, Anik and Dai, Caihong and Shaver, Joseph C and Tripathi, Alok and Ding, Kehong and Pacholczyk, Rafal and Cooley, Marion A and Zhong, Roger and Johnson, Maribeth H and Chen, Jie and Bollag, Wendy B and Isales, Carlos M and Hill, William D and Hamrick, Mark W and Fulzele, Sadanand and McGee-Lawrence, Meghan E},
title = {Inhibition of AhR improves cortical bone and skeletal muscle function via preservation of neuromuscular junctions},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.192047}
}
EUVIMED